CL vs CPHI
Colgate-Palmolive Company (CL) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CL and CPHI stock pages for the full models.
Not investment advice.